[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336499-105":59,"doc-detail-336499-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","characterizing-multi-pik3ca-mutations-across-cancer-types-toward-precision-oncology","Characterizing multi-PIK3CA mutations across cancer types - Toward precision oncology","","Background: PIK3CA mutations play roles in multiple cancers, yet the biological implications of multiple concurrent mutations and how their orientation within the gene affects outcomes remain insufficiently defined. Methods: Multi-PIK3CA mutations were profiled across a pan-cancer cohort of 3564 tumors. Results: Multi-PIK3CA mutations occurred in 10.3% of PIK3CA-mutant tumors, mainly in breast and gynecological cancers, with helical-domain E542:E545 mutations restricted to trans orientation. Conclusions: Orientation-specific mutation patterns may indicate differing oncogenic potential and support biomarker development for PI3K inhibitor–guided precision oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characterizing-multi-pik3ca-mutations-across-cancer-types-toward-precision-oncology/336499/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characterizing-multi-pik3ca-mutations-across-cancer-types-toward-precision-oncology/336499.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question of this study?","Question",{"text":112,"@type":113},"The study investigates how multiple concurrent PIK3CA mutations and their gene orientations vary across cancer types, and what these patterns imply for oncogenic potential and targeted therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cohort size and approach were used to analyze multi-PIK3CA mutations?",{"text":117,"@type":113},"Researchers analyzed multi-PIK3CA mutations across a pan-cancer cohort comprising 3564 tumors to characterize mutation frequencies, sites, and co-occurrence patterns.",{"name":119,"@type":110,"acceptedAnswer":120},"How do mutation orientations differ in the helical domain versus other domains?",{"text":121,"@type":113},"Mutations in the helical domain (E542:E545) occurred exclusively in the trans orientation, whereas mutations in the kinase ABD and C2 domains mainly appeared in the cis orientation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336499,1790180231,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","DOI: 10. 1002/cam4 .70052  \nRESEAR CH ARTICLE  \nCharacterizing multi-PIK3CA mutations across cancer types: Toward precision oncology  \nKohei Nakamura1,2  | Marin Ishikawa1 | Ryutaro Kawano1 | Eriko Aimono1,3 | Takaaki Mizuno1 | Sachio Nohara4 | Shigeki Tanishima1,4 | Hideyuki Hayashi1  | Hiroshi Nishihara1 | The Keio PleSSision Group  \n1Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan 2Department of Obstetrics and Gynecology, Kumagaya General Hospital, Kumagaya, Saitama, Japan 3Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan 4Department of Biomedical Informatics, Communication Engineering Center, Electronic Systems Business Group, Mitsubishi Electric Software Co., Ltd., Amagasaki, Hyogo, Japan  \nCorrespondence  \nKohei Nakamura, Genomics Unit, Keio Cancer Center, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. [Email:](Email: knakamura320@keio.jp)[ knakamura320@keio.jp](Email: knakamura320@keio.jp)  \nFunding information  \nJapan Society for the Promotion of Science, Grant/Award Number:  \n23K08829; Japan Agency for Medical Research and Development, Grant/ Award Number: JP23ck0106872 and JP24ck0106872; the Japan Agency for Medical Research and Development (AMED), Grant/Award Number:  \nJP24ck0106872  \nAbstract  \nBackground: PIK3CA mutations are implicated in various cancers, but the implications of multiple concurrent mutations and their orientations within the gene have not been fully explored.  \nMethods: In this study, we analyzed multi-PIK3CA mutations across a diverse pan-cancer cohort comprising 3564 tumors.  \nResults: Multi-PIK3CA mutations were present in 10.3% of all PIK3CA-mutant tumors, predominantly occurring in breast and gynecological cancers. Notably, mutations within the helical domain (E542:E545) exclusively occurred in the trans-orientation, contrasting with mutations in the kinaseABD and C2 domains, which mainly appeared in the cis orientation.  \nConclusions: The distinct pattern of mutation orientations in PIK3CA suggests variable oncogenic potential, with helical domain mutations in the transorientation potentially being less oncogenic. These findings highlight the importance of mutation orientation in the PIK3CA gene as potential biomarkers for targeted therapy. This understanding is crucial for designing clinical trials that leverage PI3K inhibitors, aiming for more effective and precise cancer treatment.  \nKEYWORDS  \ncis, multi-PIK3CA mutations, PI3K inhibitor, precision oncology, trans  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e70052 .  \n[https://doi.org/10.1002/cam4.70052](https://doi.org/10.1002/cam4.70052)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 9  \n1 | INTRODUCTION  \nPIK3CA gene is responsible for producing p110a, which is a crucial component of the PI3K lipid kinase complex. This gene is typically mutated in a wide range of cancers such as endometrial and breast cancer,1 leading to increased tumor growth and cancer cell signaling.2 Historically, PI3K has been a major therapeutic target in cancer treatment, with extensive research exploring dual PI3K/mTOR inhibitors, pan-PI3K inhibitors, and p110a-specific inhibitors in various types of cancers with both wild-type and mutant PIK3CA.3,4 Despite some progress in extending progression-free survival in patients with PIK3CA-mutant tumors, the development of targeted drugs has been limited owing to severe side effects, such as hyperglycemia.5,6 Therefore, recent research has shifted focus to identifying genomic markers indicative of a high likelihood of positive treatment response, particularly in patients with PIK3CA-m","cbCaidg37vAfo6um","https://ap.wps.com/l/cbCaidg37vAfo6um","pdf",2080007,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## PIK3CA biology and therapeutic targeting\n## Rationale for multi-PIK3CA mutation investigation\n# Materials and Methods\n## Sample collection","[{\"question\":\"What is the main research question of this study?\",\"answer\":\"The study investigates how multiple concurrent PIK3CA mutations and their gene orientations vary across cancer types, and what these patterns imply for oncogenic potential and targeted therapy.\"},{\"question\":\"What cohort size and approach were used to analyze multi-PIK3CA mutations?\",\"answer\":\"Researchers analyzed multi-PIK3CA mutations across a pan-cancer cohort comprising 3564 tumors to characterize mutation frequencies, sites, and co-occurrence patterns.\"},{\"question\":\"How do mutation orientations differ in the helical domain versus other domains?\",\"answer\":\"Mutations in the helical domain (E542:E545) occurred exclusively in the trans orientation, whereas mutations in the kinase ABD and C2 domains mainly appeared in the cis orientation.\"}]","Characterizing multi-PIK3CA mutations across cancer types - Toward precision oncology | PDF",1790015358,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb954d497d32e343aeae8b984defacbe.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfb757555fdab5b9e7064f9fafb0772d.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4db6b148c9fd8d2a5bfac189a10e958.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/162d4db1450bd82a9ca5dac5410cd313.webp",980,1287]